Summary:
A 7 month long study consisting of 11 clinic visit will evaluate the efficacy, safety and tolerability of Vibegron in men with Overactive Bladder (OAB) symptoms on pharmacological therapy for Benign Prostatic Hyperplasia (BPH).
Qualified Participants Must:
• Be male and at least 45 years of age
•
Be stable on current BPH regimen for at least 3 months prior to screening
•
Not currently taking or have taken herbal medications to treat OAB or BPH symptoms within 3 months of screening
Qualified Participants May Receive:
- Compensation for time and travel expenses
- Physical performed by a board ceritifed physician
- Study related procedures (i.e. blood work and EKG)